← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (676)Review article (146)Early study (phase 1 or 2) (12)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. (2017/08/21) ♡
• Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. (2017/08/16) ♡
• Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate-activated protein kinase-related kinases and retinoid X receptor α. (2017/07/13) ♡
• MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. (2017/07/03) ♡
• Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?! (2017/07/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials. (2017/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Changed Proportion of CD45RA (+) /CD45RO (+) T Cells in Chronic Hepatitis C Patients During Pegylated Interferon-α with Ribavirin Therapy. (2017/07/01) ♡
• Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection. (2017/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Challenge of Treating Children With Hepatitis C Virus Infection. (2017/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lipid droplets and liver disease: from basic biology to clinical implications. (2017/06/01) ♡
• Estimation of State-Level Prevalence of Hepatitis C Virus Infection, U.S. States and District of Columbia, 2010. (2017/06/01) ♡
• Interleukin-22 and Chemokine Interferon γ -Inducible-10 (IP-10) Levels in Chronic Hepatitis C Patients and Treatment Response to Pegylated Interferon and Ribavirin Therapy. (2017/06/01) ♡
• Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis. (2017/06/01) ♡
• Racial disparity in all-cause mortality among hepatitis C virus-infected individuals in a general US population, NHANES III. (2017/05/01) ♡
• Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. (2017/05/01) ♡
• Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. (2017/05/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. (2017/04/26) ♡
• Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction. (2017/04/18) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo control trial. (2017/04/04) ♡
• High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. (2017/04/04) ♡
• Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. (2017/04/01) ♡
• Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. (2017/04/01) ♡
• Orange juice as a dietary source of antioxidants for patients with hepatitis C under antiviral therapy. (2017/03/22) ♡
• A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China. (2017/03/14) ♡
• Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. (2017/03/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review. (2017/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment. (2017/02/28) ♡
• Recurrence of depressive disorders after interferon-induced depression. (2017/02/07) ♡
• Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis? (2017/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study. (2017/01/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection. (2017/01/01) ♡
• Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies. (2017/01/01) ♡
• Relative validity of a food frequency questionnaire in patients infected with hepatitis C virus and human immunodeficiency virus. (2017/01/01) ♡
• Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1 Coinfected Patients. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Hepatitis C can be cured: will hepatitis B become next?]. (2017/01/01) ♡
• [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis]. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging Trends in Non-Interferon-Based Genotype-Specific Antiviral Agents: Pharmaceutical Perspectives. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Phosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection. (2017/01/01) ♡
• Long-term outcomes of thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. (2017/01/01) ♡
• [Predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis C virus genotype 1]. (2017/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rare cause of acute hepatitis: a common energy drink. (2016/11/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial. (2016/08/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.